Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.

@article{Tsuboi2004SerumIA,
  title={Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma.},
  author={Kaori Tsuboi and Tatsuya Miyazaki and Masanobu Nakajima and Yasuyuki Fukai and Norihiro Masuda and Ryokuhei Manda and Minoru Fukuchi and H. Ogata H. Kato and Hiroyuki Kuwano},
  journal={Cancer letters},
  year={2004},
  volume={205 2},
  pages={207-14}
}
Interleukin (IL)-12 and IL-18 participate in tumor immunology. Serum IL-12 and IL-18 levels were determined in patients with esophageal carcinoma, and the relationship between clinicopathologic factors and prognosis was investigated. Peripheral blood samples were obtained from 15 healthy volunteers and from 70 patients with esophageal carcinoma before… CONTINUE READING